GSK enters into a multi-year data licence agreement with ÌìÑĺ£½ÇÉçÇø to further investigate the drivers of liver disease June 12, 2024
ÌìÑĺ£½ÇÉçÇø announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease April 22, 2024